Clinical Trial Update: Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 randomized, modified double-blind, active-controlled safety study of the vYF vaccine in adults for yellow fever …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• vYF

Snippet

Sponsor: Sanofi | Conditions: Yellow Fever Immunization | Phase 3 | Status: COMPLETED